Xiao-You Jiang

Xiao-You Jiang

Auto-generated profile, based on publicly available information

Xiao-You Jiang

Clinical Translational Research Center, Shengjing Hospital, Health Sciences Institute, Key Laboratory of Medical Cell Biology, Ministry of Education, College of Basic Medical Science, Key Laboratory of Liaoning Province, Health Sciences Institute, China Medical University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
QGQiqiang Guo
Qiqiang Guo
SWShan-Shan Wang
Shan-Shan Wang
XJXiao-You Jiang
Xiao-You Jiang
XXXiao-Chen Xie
Xiao-Chen Xie
YZYu Zou
Yu Zou
LCLiu Cao
Liu Cao
The homeostatic link between the production of mitochondrial ROS (mtROS) and mitophagy plays a significant role in how cells respond to various physiological and pathological conditions. However, it remains unclear how cells translate oxidative stress signals into adaptive mitophagy responses. Here, we show that mtROS act as signaling molecules that activate the ataxia-telangiectasia mutated (ATM)-cell cycle checkpoint kinase 2 (CHK2), a DNA damage response (DDR) pathway. When activated, CHK2 regulates three critical steps in mitophagy. First, CHK2 phosphorylates mitochondrial membrane protein ATAD3A at Ser371, which inhibits the transport of PINK1 to the inner mitochondrial membrane and leads to the accumulation of PINK1 and the commencement of mitophagy. Second, activated CHK2 targets the autophagy adaptor OPTN at Ser177 and Ser473, thereby enhancing the targeting of ubiquitinated mitochondria to autophagosomes. Finally, CHK2 phosphorylates Beclin 1 at Ser90 and Ser93, hence promoting the formation of autophagosomal membranes. Consistent with these effects, Chk2 −/− mice show impaired mitophagic induction and impaired recovery in a ROS-dependent model of renal ischemia–reperfusion. Our study reveals a mtROS-triggered adaptive pathway that coordinates mitophagic induction, in order to protect cells and tissues exposed to pathophysiological stress-induced damage.

25 July 2025 in Science Advances
Verified
Journal Article
Open access
XJXiao-You Jiang
Xiao-You Jiang
QGQiqiang Guo
Qiqiang Guo
SWShan-Shan Wang
Shan-Shan Wang
RGRan Guo
Ran Guo
YZYu Zou
Yu Zou
LCLiu Cao
Liu Cao
Nrf2 acts as a transcriptional master regulator to orchestrate antioxidant responses and maintain redox balance. However, the cellular pathway for translating oxidative stress signals into Nrf2-dependent antioxidant responses remain incompletely understood. Here, we show that reactive oxygen species (ROS) function as signaling molecules in modulating Nrf2’s stability and transcriptional activity by activating the DNA damage response (DDR) signaling pathway. When activated, CHK2 phosphorylates the autophagy adaptor protein p62 at serine-349, promoting its interaction with Keap1 and disrupting the Keap1-Nrf2 interaction, thereby inhibiting Nrf2 ubiquitination–dependent degradation. In addition, CHK2 directly phosphorylates Nrf2 at serine-566/serine-577, enhancing its transcriptional activity and antioxidant capacity. Consistent with these effects, Chk2 −/− mice show impaired expression of Nrf2 and its downstream antioxidant target genes, along with more severe renal tissue damage in an ROS-dependent model of renal ischemia/reperfusion injury. Our study reveals a direct mechanism linking the DDR signaling pathway to ROS-triggered Nrf2-dependent antioxidant responses, providing critical insight into cellular protection against oxidative stress–induced damage.

29 December 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YGYi Guan
Yi Guan
YYYang Yu
Yang Yu
MFMengdi Fu
Mengdi Fu
HXHongde Xu
Hongde Xu
ELEunyoung Lee
Eunyoung Lee
LCLiu Cao
Liu Cao
Diabetes and insulin resistance (IR) remain major global health challenges, underscoring the need for novel therapeutic strategies. Here, we identify an autophagy-independent role of circulating autophagy-related gene 7 (ATG7) in metabolic regulation. Circulating ATG7 enhances insulin sensitivity and glucose homeostasis by directly interacting with IRS1 and modulating insulin signaling (IS) through liver–muscle crosstalk. Mechanistically, ATG7 binds to IRS1, promoting its activation and the propagation of downstream IS. Notably, we identify an ATG7-derived peptide (Aap2) that recapitulates ATG7’s insulin-sensitizing effects and improves glycemic control in both Type 1 and Type 2 diabetic mouse models. These findings establish ATG7 as a key regulator of IS and suggest that targeting ATG7 may represent a promising therapeutic approach for IR and diabetes.